purine has been researched along with Liver Neoplasms in 14 studies
1H-purine : The 1H-tautomer of purine.
3H-purine : The 3H-tautomer of purine.
9H-purine : The 9H-tautomer of purine.
7H-purine : The 7H-tautomer of purine.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Purine not only acts as a metabolic substrate of XOR for UA production, but it induces inflammation through IFN-γ secretion that stimulates UA production through elevation of XOR expression." | 4.12 | Purine-Induced IFN-γ Promotes Uric Acid Production by Upregulating Xanthine Oxidoreductase Expression. ( Huang, D; Li, X; Liang, B; Lin, Z; Song, X; Su, T; Wang, H; Wang, J; Xie, L, 2022) |
| "Purine analogs have been reported to be effective against chronic lymphocytic leukemia and indolent lymphomas." | 1.32 | Early reappearance of primary solid cancer in patients treated with purine analogs. ( Caracciolo, F; Fazzi, R; Galimberti, S; Petrini, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, H | 1 |
| Xie, L | 1 |
| Song, X | 1 |
| Wang, J | 1 |
| Li, X | 1 |
| Lin, Z | 1 |
| Su, T | 1 |
| Liang, B | 1 |
| Huang, D | 2 |
| Zhao, JZ | 2 |
| Wang, W | 2 |
| Liu, T | 2 |
| Zhang, L | 2 |
| Lin, DZ | 2 |
| Yao, JY | 2 |
| Peng, X | 2 |
| Jin, G | 2 |
| Ma, TT | 2 |
| Gao, JB | 2 |
| Huang, F | 2 |
| Nie, J | 2 |
| Lv, Q | 2 |
| Hung, MH | 1 |
| Chang, CW | 1 |
| Wang, KC | 1 |
| Chaisaingmongkol, J | 1 |
| Ruchirawat, M | 1 |
| Greten, TF | 1 |
| Wang, XW | 1 |
| Ma, F | 1 |
| Zhu, Y | 1 |
| Liu, X | 1 |
| Zhou, Q | 1 |
| Hong, X | 1 |
| Qu, C | 1 |
| Feng, X | 1 |
| Zhang, Y | 1 |
| Ding, Q | 1 |
| Zhao, J | 1 |
| Hou, J | 1 |
| Zhong, M | 1 |
| Zhuo, H | 1 |
| Zhong, L | 1 |
| Ye, Z | 1 |
| Xie, W | 1 |
| Liu, Y | 1 |
| Xiong, Y | 1 |
| Chen, H | 1 |
| Piao, D | 1 |
| Sun, B | 1 |
| Gao, Z | 1 |
| Li, Q | 1 |
| Zhang, Z | 2 |
| Qiu, X | 1 |
| Liu, H | 1 |
| McArthur, DL | 1 |
| Boros, LG | 1 |
| Nissen, N | 1 |
| Heaney, AP | 1 |
| Kotlyar, DS | 1 |
| Osterman, MT | 1 |
| Diamond, RH | 1 |
| Porter, D | 1 |
| Blonski, WC | 1 |
| Wasik, M | 1 |
| Sampat, S | 1 |
| Mendizabal, M | 1 |
| Lin, MV | 1 |
| Lichtenstein, GR | 1 |
| Fazzi, R | 1 |
| Caracciolo, F | 1 |
| Galimberti, S | 1 |
| Petrini, M | 1 |
| WERKHEISER, WC | 1 |
| WINZLER, RJ | 1 |
| VISSER, DW | 1 |
| DE LAMIRANDE, G | 1 |
| ALLARD, C | 1 |
| CANTERO, A | 1 |
| SARTORELLI, AC | 2 |
| BOOTH, BA | 2 |
| WHEELER, GP | 1 |
| ALEXANDER, JA | 1 |
| DODSON, AS | 1 |
| BRIGGS, SD | 1 |
| MORRIS, HP | 1 |
| LARSSON, A | 1 |
| POTTER, VR | 1 |
1 review available for purine and Liver Neoplasms
| Article | Year |
|---|---|
A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Humans; Immunologic Factors; | 2011 |
13 other studies available for purine and Liver Neoplasms
| Article | Year |
|---|---|
Purine-Induced IFN-γ Promotes Uric Acid Production by Upregulating Xanthine Oxidoreductase Expression.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Hepatocytes; Humans; Inflammation; Interferon-gamma; Ju | 2022 |
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre | 2022 |
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre | 2022 |
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre | 2022 |
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre | 2022 |
Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma through m 6 A-mediated epitranscriptomic regulation.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Damage; DNA Repair; Epigenesis, Genetic; Gene Expre | 2023 |
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Loss Activates Purine Metabolism and Promotes Hepatocellular Carcinoma Progression.
Topics: Activating Transcription Factor 4; Carcinoma, Hepatocellular; Disease Progression; Humans; Liver Neo | 2019 |
Fructose induces transketolase flux to promote pancreatic cancer growth.
Topics: Cell Growth Processes; Cell Line, Tumor; Enzyme Induction; Fructose; Glucose; Hepatoblastoma; Humans | 2010 |
Early reappearance of primary solid cancer in patients treated with purine analogs.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Colic; Female; Humans; Liver Neoplasms; Mal | 2003 |
Metabolic inhibitors and nucleotide turnover. I. Inhibition of uptake of radiophosphate in rat liver and hepatoma slices.
Topics: Animals; Carcinoma, Hepatocellular; Liver; Liver Neoplasms; Neoplasms; Nucleic Acids; Nucleotides; P | 1955 |
Purine-metabolizing enzymes in normal rat liver and Novikoff hepatoma.
Topics: Animals; Carcinoma, Hepatocellular; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Metabolic | 1958 |
Utilization of preformed purines by sarcoma 180 or hepatoma 134 cells treated with 6-chloropurine or a combination of 6-chloropurine and azaserine.
Topics: Animals; Antineoplastic Agents; Azaserine; Carcinoma, Hepatocellular; Liver Neoplasms; Neoplasms; Pu | 1960 |
Searches for exploitable biochemical differences between normal and cancer cells. IX. Anabolism and catabolism of purines by hepatomas 5123 and H-35.
Topics: Animals; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Purines | 1962 |
GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azaguanine; Azaserine; Carcinoma, Ehrlich Tumor; | 1963 |
ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOTIDES. III. REDUCTION OF PURINE RIBONUCLEOTIDES WITH AN ENZYME SYSTEM FROM ESCHERICHIA COLI B.
Topics: Adenine Nucleotides; Carcinoma, Hepatocellular; Deoxyribonucleotides; Escherichia coli; Guanine Nucl | 1963 |
NEW PROSPECTS IN CANCER BIOCHEMISTRY.
Topics: Antineoplastic Agents; Carbohydrate Metabolism; Carcinoma, Hepatocellular; Feedback; Glucose; Glucos | 1963 |